ICAR develops indigenous vaccine for African swine fever
Scientists at ICAR-National Institute of High Security Animal Diseases (ICAR-NIHSAD), Bhopal, have developed the vaccine using a novel attenuated ASFV Genotype II virus
The Indian Council of Agricultural Research (ICAR) has developed India's first indigenous vaccine for African swine fever (ASF), marking a significant advancement in animal health. ASF is considered one of the most devastating trans-boundary animal diseases affecting both domestic and wild pigs worldwide, with mortality rates potentially reaching 100%.
The vaccine, created using a novel attenuated "ASFV Genotype II virus" by scientists at ICAR-NIHSAD in Bhopal, has undergone rigorous laboratory testing, including sterility, purity, safety, and immunogenicity studies. The vaccine is recommended for healthy pigs above eight weeks of age and requires a booster dose 14 days after the primary vaccination.
The development of this indigenous vaccine is expected to substantially reduce pig mortality, minimize economic losses, and improve the livelihoods of pig farmers across the country.
Brief written by urgent.news from The Hindu's own syndicated text. Machine-written — may contain errors; check the original before relying on it.
